Next Article in Journal
Effect of Sulforaphane and 5-Aza-2’-Deoxycytidine on Melanoma Cell Growth
Previous Article in Journal
Ethnomedicinal Uses of Plant Resources in the Machhapuchchhre Rural Municipality of Kaski District, Nepal
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Phytochemical Screening, Free Radical Scavenging and α-Amylase Inhibitory Activities of Selected Medicinal Plants from Western Nepal

1
School of Health and Allied Sciences, Faculty of Health Sciences, Pokhara University, Pokhara 33700, Nepal
2
Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oehonmachi, Chuo-ku, Kumamoto 862-0973, Japan
*
Author to whom correspondence should be addressed.
Medicines 2019, 6(2), 70; https://doi.org/10.3390/medicines6020070
Submission received: 10 May 2019 / Revised: 14 June 2019 / Accepted: 20 June 2019 / Published: 25 June 2019

Abstract

:
Background: More than 700 plants are reported to be used for medicinal purposes in Nepal; however, many of them are not studied for their scientific evidences. The aims of the present study were the estimation of the total phenolic and flavonoid contents, and the evaluation of the free radical scavenging and α-amylase inhibitory activities of five selected medicinal plants from western Nepal: Aeschynanthus parviflorus Wall. (Gesneriaceae), Buddleja asiatica Lour. (Loganiaceae), Carica papaya L. (Caricaceae), Drepanostachyum falcatum (Nees) Keng f. (Gramineae) and Spondias pinnata (L. f.) Kurz (Anacardiaceae). Methods: The total phenolic content (TPC) and total flavonoid content (TFC) were measured using Folin-Ciocalteu’s phenol reagent and aluminium chloride methods, respectively. A 1,1–diphenyl–2–picrylhydrazyl (DPPH) free radical scavenging assay was used to evaluate the free radical scavenging activity and an α-amylase inhibitory assay was carried out to determine the in vitro antidiabetic activity. Results: The phytochemical screening of five hydroalcoholic plant extracts revealed the presence of various secondary metabolites, including alkaloids, flavonoids, reducing sugars, saponins, terpenoids and tannins. The amounts of total phenolics and flavonoids were found to be the highest in B. asiatica leaf extract, which also showed the most potent free radical scavenging activity. Extract of C. papaya fruits showed the highest α-amylase inhibitory activity, whereas the extracts of B. asiatica leaves and S. pinnata leaves exhibited moderate activity. Conclusions: Some of the medicinal plants selected in this study showed high TPC and TFC values and potent bioactivities. These results may provide the scientific evidences of the traditional uses of these plants. However, further detailed studies on bioactive compounds isolation and identification and evaluation of in vivo pharmacological activities should be performed in future.

1. Introduction

In most developing countries, medicinal plants and their products are utilized as important therapeutic agents for treating various diseases [1,2]. Countries in South Asia, including Nepal and India, have a long history, since the Vedic period, of using crude drugs obtained from plant sources as medicine [3]. Nepal is a small landlocked country blessed with a natural and cultural diversity. The biodiversity of Nepal is unique due to its climatic conditions and many isolated topographical locations. More than 700 plants are reported to be used for medicinal purposes in Nepal [1,4,5]. However, these resources have been underutilized, and there is still a huge potential for researchers to explore the floristic and faunal diversity. There are many medicinal herbs yet to be studied for their bioactive chemical constituents and potential therapeutic activities. Although these medicinal plants are used by ethnic people for various purposes, there is very limited information available regarding their mechanisms of action, dose, frequency, side effects and many other factors that otherwise would be very necessary to provide scientific evidences. Thus, in this study, we selected the following five plants, i.e., Aeschynanthus parviflorus Wall. (Gesneriaceae), Buddleja asiatica Lour. (Loganiaceae), Carica papaya L. (Caricaceae), Drepanostachyum falcatum (Nees) Keng f. (Gramineae) and Spondias pinnata (L. f.) Kurz (Anacardiaceae), from Western Nepal and screened for their phytochemical constituents and biological activities.
A. parviflorus is an epiphytic sub-shrub distributed in India, Nepal, Sikkim, Bhutan, Southern China, Burma, Thailand and Vietnam [6]. Root decoction is used for the treatment of fever, and the infusion of leaves is used to treat tonsillitis in Mizoram, India [7]. Plant juice, about 4 teaspoons twice a day, helps to conceive. Powdered leaf, mixed with rice flour, is baked and taken for backaches [4].
B. asiatica, also called butterfly bush, is an evergreen shrub endemic to East Asian countries including India and Nepal [8]. In Nepal, the leaves and flowers are used as a religious offering to gods and goddesses. Squeezed leaves are used as a fish poison. The plant juice or paste is used for diarrhea, skin diseases and beverage fermentation [9].
C. papaya is a tropical tree, native to central America and now widely cultivated in all tropical and sub-tropical regions for its edible fruits and its latex [10]. The medicinal properties of C. papaya are well documented in traditional systems of medicine [11] Latex of papaya is anthelmintic and used for wound healing and skin diseases. Leaf decoction is used for asthma and rheumatism. The unripe fruits are used as a laxative and diuretic [12,13].
D. falcatum, also called hill bamboo, is a herb commonly found in the subtropical forest in Nepal, Bhutan and India [14]. This plant has a religious importance in Nepal as it is frequently used in Hindu marriages and house warming rituals. It is also used as an effective soil stabilizer in farming [15]. Young shoots are cooked as vegetable, and the stems are used in making baskets, mats and as fodder [4].
S. pinnata is a deciduous tree, 10–15 m tall, indigenous to Southeast Asian countries [16,17]. Different parts of S. pinnata (leaves, bark, fruits, and roots) have been used for the treatment of various disorders. For example, the fresh leaves of S. pinnata are used to treat gastrointestinal disorders, and the ripe fruits are consumed raw or as juice as a liver tonic and appetizer in Nagaland, India [18]. The bark is used for the treatment of dysentery, muscular rheumatism and diabetes mellitus [19]. The fruits are eaten fresh or pickled. Bark decoction is given for dysentery, gonorrhea and rheumatism [20]. The roots are used for regulating menstruation [21].
The main aims of the present study were the estimation of the total phenolic and flavonoid contents, and the evaluation of the free radical scavenging and α-amylase inhibitory activities of these five medicinal plants.

2. Materials and Methods

2.1. Chemicals

1,1–Diphenyl–2–picrylhydrazyl (DPPH), gallic acid and quercetin were purchased from Wako Pure Chemicals, Osaka, Japan. α-Amylase was obtained from Hi-Media Laboratories, Mumbai, India. Ascorbic acid, aluminium chloride and starch were procured from Qualigens Fine Chemicals, Mumbai, India. Folin-Ciocalteu’s phenol reagent was obtained from Sigma Aldrich, St. Louis, MO, USA.

2.2. Plant Materials

Five plant species (Table 1) were collected from different localities of Kaski district, Western Nepal, during the month of August, 2017. The plant species were identified by Dr. Radheshyam Kayastha, Former Professor, Tribhuvan University, Nepal. The voucher specimens were deposited at the Laboratory of Pharmacognosy, Pokhara University, Nepal. Their voucher specimen numbers are given in Table 1.

2.3. Extraction

The dried plant samples (30–50 g) were macerated twice with 80% ethanol (1:8 w/v) for 24 h in a closed vessel with occasional shaking. The filtered extracts were then dried through the use of a rotary evaporator. The percentage yield of the extracts (Table 1) was calculated using the following equation: yield (%) = (weight of extract / weight of dried plant material) × 100 [22].

2.4. Phytochemical Screening

The extracts obtained from the selected plant parts were subjected to a preliminary screening to identify the secondary metabolites, using different phytochemical tests [23].

2.5. Determination of Total Phenolic Content (TPC)

The TPC of the plant extracts was determined using Folin-Ciocalteu’s phenol reagent method as described by Hazra et al. [24], with a slight modification. In brief, 1 mL of extract (1 mg/mL) was mixed with 5 mL of distilled water and 1 mL of Folin-Ciocalteu’s phenol reagent. After 5 min, 1 mL of 10% (w/v) sodium carbonate was added and mixed properly. The mixture was allowed to stand for 1 h at room temperature, and then the absorbance was measured at 725 nm using a UV spectrophotometer. The TPC of each extract was calculated using an equation obtained from the standard calibration curve of gallic acid and was expressed in terms of the gallic acid equivalent (mg of GAE/g of extract). All experiments were performed in triplicate.

2.6. Determination of Total Flavonoid Content (TFC)

The content of the flavonoids in the plant extracts was performed using the aluminium chloride colorimetric method by Chang et al. [25], with a slight modification. In brief, 1 mL of extract (1 mg/mL) was mixed with 4 mL of distilled water, and 0.3 mL of 5% sodium nitrite was added. After 5 min, 0.3 mL 20% aluminium chloride was added and allowed to stand for 6 min. Then, 2 mL of 1 M sodium hydroxide was added. The mixture was shaken, and the absorbance was measured at 510 nm using a UV spectrophotometer. The TFC of each extract was calculated using an equation obtained from the standard calibration curve of quercetin and was expressed in terms of the quercetin equivalent (mg of quercetin/g of extract). All experiments were performed in triplicate.

2.7. Free Radical Scavenging Activity

The antioxidant activity of the plant extracts was determined using the DPPH free radical scavenging assay [26], with a slight modification. Briefly, 2 mL of different concentrations of extract/standard solution were mixed with 2 mL of 60 μM DPPH solution. After mixing, the mixture was incubated for 30 min in dark at room temperature, and the absorbance was measured at 517 nm using a UV spectrophotometer. Ascorbic acid was used as a positive control. The scavenging activity of each sample against the DPPH free radical was calculated using the following equation: Scavenging Activity (%) = [(Ac − As)/Ac] × 100. Where, Ac = Absorbance of the control and As = Absorbance of the sample. A graph was obtained by plotting the scavenging activity (%) against the concentration, and the inhibitory concentration (IC50) value was calculated, which is defined as the concentration of the sample required to scavenge 50% of the DPPH free radicals. All experiments were performed in triplicate.

2.8. In Vitro α-Amylase Inhibitory Activity

The α-amylase inhibitory assay was performed through the modified starch iodine protocol [27], with a slight modification. In brief, 1 mL of plant extract/standard of different concentrations (0.25 mg/mL, 0.5 mg/mL, 1 mg/mL, and 2 mg/mL) was added to 1 mL of 0.02 M phosphate buffer (pH 6.9 with 0.006 M NaCl) containing α-amylase (1 mg/mL) solution and was be incubated at 37 °C for 10 min. Then, 1 mL of 1% starch solution was added to each test tube. The reaction mixture was then incubated at 37 °C for 1 h. After incubation, the reaction was stopped by adding 0.04 mL of 1 M HCl, followed by the addition of 0.1 mL of 1% iodine reagent. The absorbance was measured at 565 nm using a UV spectrophotometer. The percentage inhibition was calculated by using the following expression: Percentage inhibition = [(As − Ac)/As] × 100. Where, Ac is the absorbance of the control and As is the absorbance of the sample. From these data, a curve was plotted, and the inhibitory concentration (IC50) value was calculated, which is defined as the concentration of the samples required for a 50% inhibition of enzyme. All experiments were performed in triplicate.

2.9. Statistical Analysis

The results were expressed as the mean ± SD (n = 3). All of the data analyses were carried out using Microsoft Excel 2007.

3. Results

3.1. Extraction and Phytochemical Screening

The extraction yields of the extracts are given in Table 1. The phytochemical screening of the plant extracts showed the presence of various phytochemicals, such as alkaloids, flavonoids, reducing sugars, saponins, terpenoids and tannins, as shown in Table 2.

3.2. Total Phenolic and Flavonoid Contents (TPC and TFC)

The TPC was expressed as the GAE/g of extract using a standard calibration curve of gallic acid (y = 0.0097x + 0.2507, r2 = 0.9924). Similarly, The TFC was expressed as the QE/g of extract using a calibration curve of quercetin (y = 0.0004x + 0.1243, r2 = 0.995). The amounts TPC and TFC were found to be highest in extracts of B. asiatica leaves (127.48 ± 1.58 mg GAE/g, and 648.42 ± 2.88 mg QE/g, respectively), followed by S. pinnata leaves (71.50 ± 1.39 mg GAE/g, and 425.08 ± 1.44 mg QE/g, respectively). The D. falcatum shoots extract showed the lowest phenolic and flavonoid contents (Table 3).

3.3. DPPH Free Radical Scavenging Activity

The results of the DPPH free radical scavenging activities are expressed as IC50 (μg/mL) in Table 4. The B. asiatica leaf extract exhibited the strongest free radical scavenging activity with an IC50 value of 3.04 ± 0.04 μg/mL, followed by the S. pinnata leaf extract (IC50 = 4.84 ± 0.12 μg/mL), when compared to the positive control, ascorbic acid (IC50 = 3.16 ± 0.03 μg/mL).

3.4. α-Amylase Inhibitory Activity

The results of the α-amylase inhibitory activity of the extracts are given in Table 4. Among the tested samples, the C. papaya fruit extract showed the most potent activity with an IC50 value of 0.45 ± 0.02 mg/mL. Similarly, the B. asiatica leaves (IC50 = 1.59 ± 0.01 mg/mL) and S. pinnata leaves (IC50 = 2.11 ± 0.01 mg/mL) exhibited a moderate inhibitory activity against the α-amylase enzyme.

4. Discussion

Plants contain diverse bioactive compounds, also known as secondary metabolites, which are reported to exhibit various health promoting activities in the human body, including antioxidant activity [28,29]. One such chemical class is phenolic compounds, which are widely distributed in plants and are included as an important part of the human diet owing to their antioxidant and various other medicinal properties [30]. Flavonoids are the largest group of naturally occurring phenolic compounds; they are reported to have various biological activities including antioxidant, antimicrobial, antiulcer, antidiabetic, hepatoprotective and anticarcinogenic activities [31]. In this study, the results showed that S. pinnata leaves and B. asiatica leaf extracts have a potent antioxidant activity with IC50 values of 4.84 ± 0.12 μg/mL and 3.04 ± 0.04 μg/mL respectively, as compared to the positive control, ascorbic acid (IC50 = 3.16 ± 0.03 μg/mL). The total phenolic and flavonoid contents were also found to be higher in these extracts (Table 3). Therefore, the strong antioxidant activity of S. pinnata and B. asiatica leaf extracts can be connected with their high amount of phenolics and flavonoids. This result further supports that the antioxidant activity of these plants is in agreement with their total phenolic and flavonoid contents, as stated in previous studies [24,32]. Phenolic compounds and flavonoids with unsubstituted hydroxyl groups have been recognized as potent free radical scavengers [33,34]
α-Amylase hydrolyses α-linked polysaccharides such as starch and glycogen. [35]. α-Amylase inhibitors, e.g., acarbose and α-glucosidase inhibitors e.g., voglibose reduce the postprandial glucose levels by competitively inhibiting these hydrolase enzymes, thus delaying the absorption of glucose [36]. In our study, the α-amylase inhibitory activity of C. papaya was found to be higher, among the studied plant samples, with an IC50 value of 0.45 ± 0.02 mg/mL. B. asiatica leaves (IC50 = 1.59 ± 0.01 mg/mL) and S. pinnata leaves (IC50 = 2.11 ± 0.01 mg/mL) exhibited a moderate activity against α-amylase. However, these results should be compared with positive control e.g., acarbose in future studies. The phytochemical screening of C. papaya fruit extract revealed the presence of alkaloid, reducing sugar, saponin and tannin in this study. From previous studies, it is well known that phenolic compounds, including flavonoids and tannins, are useful for the prevention and management of diabetes mellitus [37,38,39]. Recent studies have reported the enzyme inhibitory actions of plant phenolics, with a strong inhibitory effect on α-glucosidase but a mild effect on α-amylase, thus suggesting its use for the treatment and management of diabetes [40]. The inhibition and slowing down of the activity of carbohydrate metabolizing enzymes, such as α-amylase or α-glucosidase, are referred as potential therapeutic targets in diabetes [41].
There have been some previous studies on the chemical constituents and bioactivities of these selected plants. B. asiatica possess different classes of phytochemicals, including flavonoids, sterols, iridoid glucosides, triterpenoids, phenylpropanoid esters and non-phenolic compounds [42]. 6–O–(3″, 4″–Dimethoxycinnamoyl) catalpol was isolated from the flowering parts of B. asiatica [43]. Similarly, 3,4 dihydroxy phenylethyl alcohol 8–O[(4′–O-feruoyl)–α–L–rhamnopyranosyl–(1″→3′)–β–D-glucopyranosyl–(1‴→6′)]–β–D–glucopyranoside was isolated from the leaves [44]. B. asiatica has been reported to exhibit different pharmacological activities, including antibacterial, antifungal, antispasmodic, cytotoxic, anti-inflammatory and antihepatotoxic activities [45]. C. papaya is well known for its nutritive and medicinal values. The unripe pulp of C. papaya contains phytochemicals, such as saponins and cardinolides, as well as minerals, including potassium, sodium, calcium, iron, phosphorus, zinc, copper and magnesium [46]. Similarly, the HPLC profile of C. papaya leaves showed flavonols–manghaslin, clitorin, rutin, nicotiflorin, and piperidine alkaloids–carpamic acid, methyl carpamate and carpaine [47]. The aqueous extract of C. papaya leaves is reported to exhibit an anti-tumor activity against human lymphocytes and showed immunomodulatory effects [48]. Extensive studies on the chemical isolation and biological activities of D. falcatum and A. parviflorus have not been reported yet. In this study, a preliminary phytochemical screening of A. parviflorus and D. falcatum hydroethanolic extracts only showed the presence of terpenoids among the different phytochemicals that were tested. Both plant extracts exhibited a poor free radical scavenging activity and α-amylase inhibitory activity, and they also possess a low quantity of total phenols and flavonoids. S. pinnata is known to exhibit various pharmacological activities, such as antimicrobial, antidiabetic, ulcer-protective, anticancer, antidiarrhoeal, anthelmintic, cytotoxic and hepatoprotective activities [49]. The methanol extract of the S. pinnata bark showed a promising hypoglycemic activity in normal and alloxan induced diabetic rats [50]. Methyl gallate isolated from the S. pinnata bark exhibited an anticancer activity by the induction of a sustained extracellular signal-regulated kinase 1/2 activation and apoptosis in human glioblastoma [51]. A study on the nutraceutical and therapeutic potential of raw S. pinnata has also revealed that its fruits are rich in amino acids, calcium, phosphorus, ascorbic acid and malic acid [52]. Further detailed studies on the bioassay-guided isolation and identification of compounds are necessary to identify promising leads for therapeutic applications.

5. Conclusions

In this study, five medicinal plants from western Nepal were screened for their phytochemical constituents, and their free radical scavenging and α-amylase inhibitory activities. The results concluded that S. pinnata and B. asiatica leaf extracts were found to possess a strong antioxidant activity and higher contents of total phenol and flavonoid. The α-Amylase inhibitory activity of C. papaya fruits was found to be higher among the tested plant samples, whereas B. asiatica and S. pinnata leaves exhibited a moderate activity. Further studies should focus on the bioassay-guided chemical analysis and in-vivo bioactivity evaluations.

Author Contributions

Conceptualization, H.P.D. and K.R.J.; methodology, K.S., R.T., H.P.D. and K.R.J.; writing—original draft preparation, K.S. and H.P.D.; writing—review and editing, K.S. and H.P.D.; supervision, H.P.D. and K.R.J.

Funding

This research received no external funding.

Acknowledgments

The authors would like to acknowledge School of Health and Allied Sciences, Faculty of Health Sciences, Pokhara University for space and laboratory facilities.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Devkota, H.P.; Adhikari-Devkota, A.; Takano, A.; Yahara, S.; Basnet, P. HPLC and TLC Fingerprints of Selected Nepalese Natural Medicines and Medicinal Plants. J. Nepal Pharm. Assoc. 2017, 28, 1–11. [Google Scholar]
  2. Joseph, B.; Jini, D. Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac. J. Trop. Dis. 2013, 3, 93–102. [Google Scholar] [CrossRef]
  3. Pandey, M.M.; Rastogi, S.; Rawat, A.K.S. Indian traditional ayurvedic system of medicine and nutritional supplementation. Evid. Based Complement. Altern. Med. 2013, 2013. [Google Scholar] [CrossRef] [PubMed]
  4. Manandhar, N.P. Plants and People of Nepal; Timber Press, Inc.: Portland, OR, USA, 2002. [Google Scholar]
  5. Watanabe, T.; Rajbhandari, K.R.; Malla, K.J.; Devkota, H.P.; Yahara, S. A Handbook of Medicinal Plants of Nepal Supplement I; Kobfai Publ. Project: Kanagawa, Japan, 2013. [Google Scholar]
  6. Middleton, D.J. A Revision of Aeschynanthus (Gesneriaceae) in Cambodia, Laos and Vietnam. Edinb. J. Bot. 2009, 66, 391–446. [Google Scholar] [CrossRef]
  7. Lalzarzovi, S.T.; Lalramnghinglova, H. Traditional use of medicinal plants found within Aizawl city in Mizoram, India. Pleione 2016, 10, 269–277. [Google Scholar]
  8. Sundararajan, R.; Ilengesan, R. In vitro Antioxidant Assay of Methanol Extract of Buddleja asiatica. Free Radic. Antioxid. 2018, 8, 55–61. [Google Scholar]
  9. Namsa, N.D.; Mandal, M.; Tangjang, S.; Mandal, S.C. Ethnobotany of the Monpa ethnic group at Arunachal Pradesh, India. J. Ethnobiol. Ethno. 2011, 7, 31. [Google Scholar] [CrossRef] [PubMed]
  10. El Moussaoui, A.; Nijs, M.; Paul, C.; Wintjens, R.; Vincentelli, J.; Azarkan, M.; Looze, Y. Revisiting the enzymes stored in the laticifers of Carica papaya in the context of their possible participation in the plant defence mechanism. Cell. Mol. Life Sci. 2001, 58, 556–570. [Google Scholar] [CrossRef]
  11. Krishna, K.L.; Paridhavi, M.; Patel, J.A. Review on nutritional, medicinal and pharmacological properties of Papaya (Carica papaya Linn.). Nat. Prod. Radiance 2008, 7, 364–373. [Google Scholar]
  12. Gurung, S.; Škalko-Basnet, N. Wound healing properties of Carica papaya latex: In vivo evaluation in mice burn model. J. Ethnopharmacol. 2009, 121, 338–341. [Google Scholar] [CrossRef]
  13. Satrija, F.; Nansen, P.; Murtini, S.; He, S. Anthelmintic activity of papaya latex against patent Heligmosomoides polygyrus infections in mice. J. Ethnopharmacol. 1995, 48, 161–164. [Google Scholar] [CrossRef]
  14. Stapleton, C.M.A. The bamboos of Nepal and Bhutan. Part III: Drepanostachyum, Himalayacalamus, Ampelocalamus, Neomicrocalamus and Chimonobambusa (Gramineae: Poaceae, Bambusoideae). Edinb. J. Bot. 1994, 51, 301–330. [Google Scholar] [CrossRef]
  15. Nepal, P.; Singh, M.; Baniya, A.; Singh, S.; Sainju, H.K.; Shrestha, R. Comparative Antioxidant, Antimicrobial and Phytochemical Assesments of Leaves of Desmostachya bipinnata L. Stapf, Hordeum vulgare L. and Drepanostachyum falcatum (Nees) Keng f. Nepal J. Biotechnol. 2019, 6, 1–10. [Google Scholar] [CrossRef]
  16. Baral, S.R.; Kurmi, P.P. A Compendium of Medicinal Plants in Nepal; International Union for the Conservation of Nature and Natural Resources: Kathmandu, Nepal, 2006. [Google Scholar]
  17. Rammant, E.; Bultijnck, R.; Sundahl, N.; Ost, P.; Pauwels, N.S.; Deforche, B.; Pieters, R.; Decaestecker, K.; Fonteyne, V. Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer: A systematic review protocol. BMJ Open 2017, 7, e016054. [Google Scholar] [CrossRef] [PubMed]
  18. Akter, K.; Harrington, D.; Vemulpad, S.R.; Malewska, T.; Kichu, M.; Imchen, I.; Kohen, J.; Jamie, J.F. An ethnobotanical study of medicinal plants of Chungtia village, Nagaland, India. J. Ethnopharmacol. 2015, 166, 5–17. [Google Scholar]
  19. Attanayake, A.P.; Jayatilaka, K.A.P.W.; Pathirana, C.; Mudduwa, L.K.B. Antihyperglycaemic, antihyperlipidaemic and β cell regenerative effects of Spondias pinnata (Linn. f.) Kurz. bark extract on streptozotocin induced diabetic rats. Eur. J. Integr. Med. 2014, 6, 588–596. [Google Scholar] [CrossRef]
  20. Das, J.; Mannan, A.; Rahman, M.; Dinar, A.M.; Uddin, M.E.; Khan, I.N.; Habib, R.; Hasan, N. Chloroform and Ethanol Extract of Spondias pinnata and its Different Pharmacological activity Like—Antioxidant, Cytotoxic, Antibacterial Potential and Phytochemical Screening through In-Vitro Method. Int. J. Res. Pharma. Biomed. Sci. 2011, 2, 1806–1812. [Google Scholar]
  21. Panda, B.K.; Patra, V.J.; Mishra, U.S.; Kar, S.; Panda, B.R.; Hati, M.R. Analgesic activities of the stem bark extract of Spondias pinata (Linn. f.) Kurz. J. Pharm. Res. 2009, 2, 825–827. [Google Scholar]
  22. Dirar, A.I.; Alsaadi, D.H.M.; Wada, M.; Mohamed, M.A.; Watanabe, T.; Devkota, H.P. Effects of extraction solvents on total phenolic and flavonoid contents and biological activities of extracts from Sudanese medicinal plants. S. Afr. J. Bot. 2018, 120, 261–267. [Google Scholar] [CrossRef]
  23. Bhatnagar, S.; Sahoo, S.; Mohapatra, A.K.; Behera, D.R. Phytochemical analysis, antioxidant and cytotoxic activity of medicinal plant Combretum roxburghii (Family: Combretaceae). Int. J. Drug Dev. Res. 2012, 4, 193–202. [Google Scholar]
  24. Hazra, B.; Biswas, S.; Mandal, N. Antioxidant and free radical scavenging activity of Spondias pinnata. BMC Complement. Altern. Med. 2008, 8, 63. [Google Scholar] [CrossRef] [PubMed]
  25. Chang, C.C.; Yang, M.H.; Wen, H.M.; Chern, J.C. Estimation of total flavonoid content in propolis by two complementary colometric methods. J. Food Drug Anal. 2002, 10, 178–182. [Google Scholar]
  26. Brand-Williams, W.; Cuvelier, M.E.; Berset, C. Use of a free radical method to evaluate antioxidant activity. LWT Food Sci. Technol. 1995, 28, 25–30. [Google Scholar] [CrossRef]
  27. Islam, A.F.M.M.; Hasan, M.R.; Hasan, A.H.M.N.; Rana, M.S.; Chowdhury, M.M.H.; Sarker, A.; Uddin, N.; Hossain, M.M. In vitro α–amylase inhibitory activity and in vivo hypoglycemic effect of methanol extract of Citrus macroptera Montr. fruit. Asian Pac. J. Trop. Biomed. 2014, 4, 473–479. [Google Scholar]
  28. Watson, D.; Baharlouei, A.; Altemimi, A.; Lightfoot, D.; Lakhssassi, N. Phytochemicals: Extraction, Isolation, and Identification of Bioactive Compounds from Plant Extracts. Plants 2017, 6, 42. [Google Scholar]
  29. Yeung, A.W.K.; Aggarwal, B.B.; Barreca, D.; Battino, M.; Belwal, T.; Horbańczuk, O.K.; Berindan, I.; Bishayee, A.; Daglia, M.; Devkota, H.P.; et al. Dietary natural products and their potential to influence health and disease including animal model studies. Anim. Sci. Pap. Rep. 2018, 36, 345–358. [Google Scholar]
  30. Balasundram, N.; Sundram, K.; Samman, S. Phenolic compounds in plants and agri-industrial by-products: Antioxidant activity, occurrence, and potential uses. Food Chem. 2006, 99, 191–203. [Google Scholar] [CrossRef]
  31. John, B.; Sulaiman, C.T.; George, S.; Reddy, V.R.K. Total phenolics and flavonoids in selected medicinal plants from Kerala. Int. J. Pharm. Pharm. Sci. 2014, 6, 406–408. [Google Scholar]
  32. Azeez, K.O.; Shaker, N.M.; El Shamy, M.M.; Mogib, M.A. Phytochemical and biological evaluation of Tephrosia apollinea. Res. J. Pharm. Biol. Chem. Sci. 2015, 6, 195–202. [Google Scholar]
  33. Hossain, M.A.; Shah, M.D.; Gnanaraj, C.; Iqbal, M. In vitro total phenolics, flavonoids contents and antioxidant activity of essential oil, various organic extracts from the leaves of tropical medicinal plant Tetrastigma from Sabah. Asian Pac. J. Trop. Med. 2011, 4, 717–721. [Google Scholar] [CrossRef] [Green Version]
  34. Adhikari-Devkota, A.; Elbashir, S.M.I.; Watanabe, T.; Devkota, H.P. Chemical constituents from the flowers of Satsuma mandarin and their free radical scavenging and α-glucosidase inhibitory activities. Nat. Prod. Res. 2019, 33, 1670–1673. [Google Scholar] [CrossRef] [PubMed]
  35. Thilagam, E.; Parimaladevi, B.; Kumarappan, C.; Chandra Mandal, S. α-Glucosidase and α-Amylase Inhibitory Activity of Senna surattensis. JAMS J. Acupunct. Meridian Stud. 2013, 6, 24–30. [Google Scholar] [CrossRef] [PubMed]
  36. Kang, W.; Song, Y.; Gu, X. α-glucosidase inhibitory in vitro and antidiabetic activity in vivo of Osmanthus fragrans. J. Med. Plants Res. 2012, 6, 2850–2856. [Google Scholar]
  37. Yang, S.; Meng, Y.; Yan, J.; Wang, N.; Xue, Z.; Zhang, H.; Fan, Y. Polysaccharide-enriched fraction from Amillariella mellea fruiting body improves insulin resistance. Molecules 2019, 24, 46. [Google Scholar] [CrossRef] [PubMed]
  38. Marrelli, M.; Amodeo, V.; Statti, G.; Conforti, F. Biological properties and bioactive components of Allium cepa L.: Focus on potential benefits in the treatment of obesity and related comorbidities. Molecules 2019, 24, 119. [Google Scholar] [CrossRef] [PubMed]
  39. Hamden, K.; Allouche, N.; Mnafgui, K.; Damak, M.; Keskes, H.; El Feki, A. In vitro anti-diabetic, anti-obesity and antioxidant proprieties of Juniperus phoenicea L. leaves from Tunisia. Asian Pac. J. Trop. Biomed. 2015, 4, S649–S655. [Google Scholar]
  40. Panda, D.K. Assessing The Impact Of Participation In Women Self-Help Group-Based Microfinance: Non-Experimental Evidences from rural Households In India. Int. J. Rural Manag. 2009, 5, 197–215. [Google Scholar] [CrossRef]
  41. Barrett, M.L.; Udani, J.K. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): A review of clinical studies on weight loss and glycemic control. Nutr. J. 2011, 10, 24. [Google Scholar] [CrossRef]
  42. Raja, S.; Ramya, I. A review on ethnopharmacology, phytochemistry and pharmacology of Buddleja asiatica. Int. J. Pharm. Sci. Res. 2016, 7, 4697–4709. [Google Scholar]
  43. El-Domiaty, M.M.; Wink, M.; Aal, M.M.A.; Abou-Hashem, M.M.; Abd-Alla, R.H. Antihepatotoxic Activity and Chemical Constituents of Buddleja asiatica Lour. Z. Nat. C 2015, 64, 11–19. [Google Scholar] [CrossRef]
  44. Mona, M.; Allia, A.; Amal, S.; Magda, I. Cytotoxic activity of Buddleja asiatica. Life Sci. J. 2013, 10, 2773–2777. [Google Scholar]
  45. Liao, Y.H.; Houghton, P.J.; Hoult, J.R.S. Novel and known constituents from Buddleja species and their activity against leukocyte eicosanoid generation. J. Nat. Prod. 1999, 62, 1241–1245. [Google Scholar] [CrossRef] [PubMed]
  46. Oloyede, O.I. Chemical profile of unripe pulp of Carica papaya. Pak. J. Nutr. 2005, 4, 379–381. [Google Scholar]
  47. Julianti, T.; De Mieri, M.; Zimmermann, S.; Ebrahimi, S.N.; Kaiser, M.; Neuburger, M.; Raith, M.; Brun, R.; Hamburger, M. HPLC-based activity profiling for antiplasmodial compounds in the traditional Indonesian medicinal plant Carica papaya L. J. Ethnopharmacol. 2014, 155, 426–434. [Google Scholar] [CrossRef]
  48. Otsuki, N.; Dang, N.H.; Kumagai, E.; Kondo, A.; Iwata, S.; Morimoto, C. Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effects. J. Ethnopharmacol. 2010, 127, 760–767. [Google Scholar] [CrossRef]
  49. Sameh, S.; Al-Sayed, E.; Labib, R.M.; Singab, A.N. Genus Spondias: A Phytochemical and Pharmacological Review. Evid. Based Complement. Altern. Med. 2018, 2018, 5382904. [Google Scholar] [CrossRef]
  50. Dash, G.K.; Mondal, S. Hypoglycemic activity of the bark of Spondias pinnata Linn. kurz. Pharmacogn. Mag. 2009, 5, 42–45. [Google Scholar]
  51. Chaudhuri, D.; Ghate, N.B.; Singh, S.S.; Mandal, N. Methyl gallate isolated from Spondias pinnata exhibits anticancer activity against human glioblastoma by induction of apoptosis and sustained extracellular signal-regulated kinase 1/2 activation. Pharmacogn. Mag. 2015, 11, 269. [Google Scholar]
  52. Satpathy, G.; Tyagi, Y.K.; Gupta, R.K. Preliminary evaluation of nutraceutical and therapeutic potential of raw Spondias pinnata K., an exotic fruit of India. Food Res. Int. 2011, 44, 2076–2087. [Google Scholar] [CrossRef]
Table 1. List of plants selected for the study, parts used, voucher specimen numbers and extract yield values.
Table 1. List of plants selected for the study, parts used, voucher specimen numbers and extract yield values.
S.N.Scientific Name (Family)Local Name (Nepali)Parts UsedVoucher Specimen No.Extract Yield (%)
1A. parviflorusThirjo Whole plantPUCD-2018-118.3
2B. asiaticaBhimsen-pati LeavesPUCD-2018-922.3
3C. papayaMewa Unripe fruitsPUCD-2018-104.0
4D. falcatumNigalo Young shootsPUCD-2018-1213.2
5S. pinnataAmara Leaves PUCD-2018-07/0832.1
Table 2. Phytochemical constituents identified in different plant samples.
Table 2. Phytochemical constituents identified in different plant samples.
Phytochemical ConstituentsSpecific TestsSamples
A. parviflorusB. asiaticaC. papayaD. falcatumS. pinnata
AlkaloidsMayer’s test-----
Hager’s test--+--
Wagner test-----
CarbohydratesMolisch’s test-++--
Benedict’s test-----
Fehling’s test-++-+
SaponinsFoam test-++-+
Phenolic CompoundsFerric chloride test-+--+
FlavonoidsAlkaline reagent test-+--+
TanninsGelatin test--+--
TerpenoidsSalkowski test+++++
+: Presence, -: Absence
Table 3. The TPC and TFC values a of the five extracts.
Table 3. The TPC and TFC values a of the five extracts.
Sample ExtractTotal Phenolic Content (mg GAE/g of Extract)Total Flavonoid Content (mg QE/g of Extract)
A. parviflorus27.48 ± 0.2551.75 ± 2.50
B. asiatica127.48 ± 1.58648.42 ± 2.88
C. papaya2.53 ± 0.2581.75 ± 2.50
D. falcatum2.43 ± 0.2913.41 ± 1.44
S. pinnata71.50 ± 1.39425.08 ± 1.44
a Values are expressed as the mean ± SD (n = 3).
Table 4. The IC50 values a for the DPPH free radical scavenging and α-amylase inhibitory activities of the extracts.
Table 4. The IC50 values a for the DPPH free radical scavenging and α-amylase inhibitory activities of the extracts.
SampleIC50 Values for the DPPH Free Radical Scavenging Assay (μg/mL)IC50 Values for the α-Amylase Inhibitory Assay (mg/mL)
A. parviflorus40.26 ± 3.444.76 ± 0.03
B. asiatica3.04 ± 0.041.59 ± 0.01
C. papaya41.73 ± 0.070.45 ± 0.02
D. falcatum> 1002.82 ± 0.05
S. pinnata4.84 ± 0.122.11 ± 0.01
Positive control3.16 ± 0.03-
a Values are expressed as the mean ± SD (n = 3).

Share and Cite

MDPI and ACS Style

Sai, K.; Thapa, R.; Devkota, H.P.; Joshi, K.R. Phytochemical Screening, Free Radical Scavenging and α-Amylase Inhibitory Activities of Selected Medicinal Plants from Western Nepal. Medicines 2019, 6, 70. https://doi.org/10.3390/medicines6020070

AMA Style

Sai K, Thapa R, Devkota HP, Joshi KR. Phytochemical Screening, Free Radical Scavenging and α-Amylase Inhibitory Activities of Selected Medicinal Plants from Western Nepal. Medicines. 2019; 6(2):70. https://doi.org/10.3390/medicines6020070

Chicago/Turabian Style

Sai, Kusum, Rashmi Thapa, Hari Prasad Devkota, and Khem Raj Joshi. 2019. "Phytochemical Screening, Free Radical Scavenging and α-Amylase Inhibitory Activities of Selected Medicinal Plants from Western Nepal" Medicines 6, no. 2: 70. https://doi.org/10.3390/medicines6020070

APA Style

Sai, K., Thapa, R., Devkota, H. P., & Joshi, K. R. (2019). Phytochemical Screening, Free Radical Scavenging and α-Amylase Inhibitory Activities of Selected Medicinal Plants from Western Nepal. Medicines, 6(2), 70. https://doi.org/10.3390/medicines6020070

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop